Literature DB >> 32977068

Autologous bone graft substitute containing rhBMP6 within autologous blood coagulum and synthetic ceramics of different particle size determines the quantity and structural pattern of bone formed in a rat subcutaneous assay.

Nikola Stokovic1, Natalia Ivanjko1, Igor Erjavec1, Milan Milosevic2, Hermann Oppermann3, Larry Shimp4, Kuber T Sampath5, Slobodan Vukicevic6.   

Abstract

Bone morphogenetic proteins (BMPs) are potent osteoinductive agents for bone tissue engineering. In order to define optimal properties of a novel autologous bone graft substitute (ABGS) containing rhBMP6 within the autologous blood coagulum (ABC) and ceramic particles as a compression resistant matrix (CRM), we explored the influence of their amount, chemical composition and particle size on the quantity and quality of bone formation in the rat subcutaneous assay. Tested ceramic particles included tricalcium phosphate (TCP), hydroxyapatite (HA) and biphasic calcium phosphate ceramic (BCP), containing TCP and HA in 80/20 ratio of different particle sizes (small 74-420 μm, medium 500-1700 μm and large 1000-4000 μm). RhBMP6 was either mixed with ABC or lyophilized on CRM prior to use with ABC. The experiments were terminated on day 21 and implants were analysed by microCT, histology and histomorphometry. Addition of CRM to ABGS containing rhBMP6 in ABC significantly increased the amount of newly formed bone and the optimal CRM/ABC ratio was found to be around 100 mg/500 μL. MicroCT analyses revealed that all tested ABGS formulations induced an extensive new bone formation and there were no differences between the two methods of rhBMP6 application as determined by the bone volume. However, the particle size played a significant role in the quantity and quality of newly formed bone. ABGS containing small particles induced new bone forming a dense trabecular network, cortical bone at the rim, bone and bone marrow in apposition to and in between ceramic particles. ABGS containing medium and large particles also resulted in new bone on the surface of particles as well as inside the pores. Histomorphometric analysis revealed that the ceramics particle size correlated with the quality of trabecular pattern of newly formed bone, bone/bone marrow ratio as observed in apposition and between particles, and the ratio between the cortical and trabecular bone. By employing rat subcutaneous implant assay, we showed for the first time that the size of synthetic ceramics particles affected the osteogenesis as defined by both the quantity and quality of ectopic bone.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMP; BMP carrier; Bone morphogenetic proteins; Bone regeneration; HA; TCP; Tissue engineering

Mesh:

Substances:

Year:  2020        PMID: 32977068     DOI: 10.1016/j.bone.2020.115654

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  3 in total

1.  Comparison of synthetic ceramic products formulated with autologous blood coagulum containing rhBMP6 for induction of bone formation.

Authors:  Nikola Stokovic; Natalia Ivanjko; Viktorija Rumenovic; Anita Breski; Kuber T Sampath; Mihaela Peric; Marko Pecina; Slobodan Vukicevic
Journal:  Int Orthop       Date:  2022-08-22       Impact factor: 3.479

2.  A novel autologous bone graft substitute containing rhBMP6 in autologous blood coagulum with synthetic ceramics for reconstruction of a large humerus segmental gunshot defect in a dog: The first veterinary patient to receive a novel osteoinductive therapy.

Authors:  Marko Pecin; Nikola Stokovic; Natalia Ivanjko; Ana Smajlovic; Mario Kreszinger; Hrvoje Capak; Zoran Vrbanac; Hermann Oppermann; Drazen Maticic; Slobodan Vukicevic
Journal:  Bone Rep       Date:  2021-02-25

3.  Long-term posterolateral spinal fusion in rabbits induced by rhBMP6 applied in autologous blood coagulum with synthetic ceramics.

Authors:  Nikola Stokovic; Natalia Ivanjko; Marko Pecin; Igor Erjavec; Ana Smajlović; Marina Milesevic; Sven Karlovic; Hrvoje Capak; Zoran Vrbanac; Drazen Maticic; Slobodan Vukicevic
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.